Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Ross

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Pigment Cell & Melanoma Research|June 22, 2020
Primary tumor characteristics and next-generation sequencing mutations as biomarkers for melanoma immunotherapy responseKimberly Loo, Gabrielle Gauvin, Iman Soliman, et al.
HIV Clinical Trials|October 29, 2014
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trialsEric Ross, Frank Tanser, Pamela Pei, et al.
Diseases of the Colon and Rectum|October 10, 2017
Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient CarePerry J Pickhardt, Kristin Edwards, David H Bruining, et al.
Annals of Surgical Oncology|April 3, 2023
The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast-Conserving Surgery: A Matched-Pair AnalysisRebecca Michelle Jordan, Luis Rivera-Sanchez, Kathryn Kelley, et al.
The Breast Journal|July 20, 2006
High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancerWendie A Berg, Irving N Weinberg, Deepa Narayanan, et al.
European Urology|April 8, 2018
Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical OutcomesAndrew G McIntosh, Benjamin T Ristau, Karen Ruth, et al.
Gynecologic Oncology|January 24, 2009
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rashRussell J Schilder, Harsh B Pathak, Anna E Lokshin, et al.
Nature Communications|August 6, 2025
A genetically tractable non-vertebrate system to study complete camera-type eye regenerationAlice Accorsi, Brenda Pardo, Eric Ross, et al.
Plos One|February 28, 2008
VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survivalJian Fu, Kathryn Fong, Alfonso Bellacosa, et al.
JAMA Oncology|December 15, 2015
Time to Surgery and Breast Cancer Survival in the United StatesRichard J Bleicher, Karen Ruth, Elin R Sigurdson, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Pigment Cell & Melanoma Research|June 22, 2020
Primary tumor characteristics and next-generation sequencing mutations as biomarkers for melanoma immunotherapy responseKimberly Loo, Gabrielle Gauvin, Iman Soliman, et al.
HIV Clinical Trials|October 29, 2014
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trialsEric Ross, Frank Tanser, Pamela Pei, et al.
Diseases of the Colon and Rectum|October 10, 2017
Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient CarePerry J Pickhardt, Kristin Edwards, David H Bruining, et al.
Annals of Surgical Oncology|April 3, 2023
The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast-Conserving Surgery: A Matched-Pair AnalysisRebecca Michelle Jordan, Luis Rivera-Sanchez, Kathryn Kelley, et al.
The Breast Journal|July 20, 2006
High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancerWendie A Berg, Irving N Weinberg, Deepa Narayanan, et al.
European Urology|April 8, 2018
Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical OutcomesAndrew G McIntosh, Benjamin T Ristau, Karen Ruth, et al.
Gynecologic Oncology|January 24, 2009
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rashRussell J Schilder, Harsh B Pathak, Anna E Lokshin, et al.
Nature Communications|August 6, 2025
A genetically tractable non-vertebrate system to study complete camera-type eye regenerationAlice Accorsi, Brenda Pardo, Eric Ross, et al.
Plos One|February 28, 2008
VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survivalJian Fu, Kathryn Fong, Alfonso Bellacosa, et al.
JAMA Oncology|December 15, 2015
Time to Surgery and Breast Cancer Survival in the United StatesRichard J Bleicher, Karen Ruth, Elin R Sigurdson, et al.
Pageof 8